Immunotherapies in transplantation and cancer: 22nd NAT meeting/2nd NAT LabEx IGO joint meeting; 1-2 June 2017, Nantes, France.

about

Immunotherapies in transplantation and cancer: 22nd NAT meeting/2nd NAT LabEx IGO joint meeting; 1-2 June 2017, Nantes, France.

Item

http://www.wikidata.org/entity/Q48517212

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Immunotherapies in transplanta ...... 1-2 June 2017, Nantes, France.

@en

Immunotherapies in transplanta ...... 1-2 June 2017, Nantes, France.

@nl

type

Item

label

Immunotherapies in transplanta ...... 1-2 June 2017, Nantes, France.

@en

Immunotherapies in transplanta ...... 1-2 June 2017, Nantes, France.

@nl

prefLabel

Immunotherapies in transplanta ...... 1-2 June 2017, Nantes, France.

@en

Immunotherapies in transplanta ...... 1-2 June 2017, Nantes, France.

@nl

P1476

Immunotherapies in transplanta ...... 1-2 June 2017, Nantes, France.

@en

P2093

Ignacio Anegon

http://www.w3.org/2001/XMLSchema#string

Maud Charpentier

http://www.w3.org/2001/XMLSchema#string

Nathalie Labarriere

http://www.w3.org/2001/XMLSchema#string

P2860

Melanoma cell lysosome secretory burst neutralizes the CTL-mediated cytotoxicity at the lytic synapse

The lymphoid lineage-specific actin-uncapping protein Rltpr is essential for costimulation via CD28 and the development of regulatory T cells

Co-recruitment analysis of the CBL and CBLB signalosomes in primary T cells identifies CD5 as a key regulator of TCR-induced ubiquitylation

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.

Multiplex Genome-Edited T-cell Manufacturing Platform for "Off-the-Shelf" Adoptive T-cell Immunotherapies.

Fully human CD19-specific chimeric antigen receptors for T-cell therapy.

Blockade of individual Notch ligands and receptors controls graft-versus-host disease

The composition of the microbiota modulates allograft rejection.

A full GMP process to select and amplify epitope-specific T lymphocytes for adoptive immunotherapy of metastatic melanoma.

The evolution of innate lymphoid cells.

P304

867-870

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/IMT-2017-0094

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sylvain Simon

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29338607

http://www.w3.org/2001/XMLSchema#string